New Drugs

FDA grants priority review to multiple myeloma treatment

The Food and Drug Administration has granted priority review for daratumumab, a monoclonal antibody ...

Sotatercept promising for treatment of anemia in MDS

FROM LANCET HAEMATOLOGY A novel agent holds promise as a treatment option for anemia ...

Gene therapy moves from promise to reality

After decades of hype, dashed hopes, and setbacks, gene therapy has finally arrived and ...

FDA grants ‘Breakthrough Therapy Designation’ for upadacitinib for atopic dermatitis

The Food and Drug Administration has granted “Breakthrough Therapy Designation” for the investigational, once-daily ...

High-dose hydrogen peroxide for SKs

Formerly known as A-101, Eskata is a novel topical treatment for seborrheic keratoses (SKs) ...

Phase 1 study: Human IL-10 plus checkpoint blockade looks promising in RCC, NSCLC

REPORTING FROM SITC 2017 NATIONAL HARBOR, MD. (FRONTLINE MEDICAL NEWS) – Pegylated human interleukin-10 ...